Neuphoria Therapeutics (NASDAQ:NEUP) Stock Price & Analysis

$3.73

USD

+0.00(0.00%)

At close: Sep 12, 01:23 EDT

Open

$3.45

Prev. Close

$3.73

High

$3.51

Low

$3.43

Company Profile

Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.

CEOSpyridon Papapetropoulos

SectorHealthcare

IndustryBiotechnology

Employees8

Recently from Cashu

IPO Date

Dec 16, 2021

ExchangeNASDAQ

Exchange NameNASDAQ Global Market

CurrencyUSD

Headquarters & Contact

Address100 Summit Dr

City / State / ZIPBurlington, MA, 01803

CountryUnited States

Websitehttp://www.neuphoriatx.com

Neuphoria Therapeutics Inc.

Company Profile

Recently from Cashu